首页 | 本学科首页   官方微博 | 高级检索  
检索        

紫七软肝片对大鼠肝纤维化湿热瘀毒证模型转化生长因子-β1和基质金属蛋白酶组织抑制剂-1表达的动态影响
引用本文:叶放,薛博瑜,周珉,周仲瑛.紫七软肝片对大鼠肝纤维化湿热瘀毒证模型转化生长因子-β1和基质金属蛋白酶组织抑制剂-1表达的动态影响[J].中西医结合肝病杂志,2008,18(5):286-288.
作者姓名:叶放  薛博瑜  周珉  周仲瑛
作者单位:南京中医药大学中医内科急难症研究所、国家中医药管理局"内科难治病瘀热病机重点研究室",江苏,南京,210029
基金项目:国家重点基础研究发展规划(973计划)中医基础理论专项,江苏省教育厅高校研究生创新计划,江苏省卫生厅中医药局研究专项
摘    要:目的:探讨紫七软肝片对复合因素致大鼠肝纤维化湿热瘀毒证模型作用的动态影响。方法:采用复合因素(CCl4+高脂饮食+酒精)干预大鼠,分正常组、模型组、紫七软肝片治疗组和秋水仙碱对照组,分别观察第4周和8周大鼠肝纤维化相关指征的变化,检测其血清透明质酸(HA)、层粘连蛋白(LN)、Ⅲ型前胶原氨端肽(PⅢP)以及采用肝组织免疫组化检测其转化生长因子-β1(TGF-β1)和基质金属蛋白酶组织抑制剂-1(TIMP-1)的动态表达情况。结果:模型组大鼠从4周和8周末HA、LN、PⅢP以及TGF-β1和TIMP-1均有不同程度的改变,并呈现动态加重的过程,而紫七软肝片和秋水仙碱均有明显的治疗作用,且紫七软肝片的作用更为明显(P〈0.05或P〈0.0l)。结论:抑制纤维组织增生、拮抗TGF-β1和TIMP-1表达等是紫七软肝片有效防治肝纤维化的重要机制。

关 键 词:肝纤维化  模型  紫七软肝片/药效学  转化生长因子-β1  基质金属蛋白酶组织抑制剂-1

Ziqi Ruangan tablet' s influence on TGF-β1 and TIMP-1 expressed in rat model for hepatic fibrosis with damp heat and toxic syndrome
YE Fang,XUE Bo-yu,ZHOU Ming,et al..Ziqi Ruangan tablet'' s influence on TGF-β1 and TIMP-1 expressed in rat model for hepatic fibrosis with damp heat and toxic syndrome[J].Chinese Journal of Integrated Traditonal and Western Medicine on Liver Diseases,2008,18(5):286-288.
Authors:YE Fang  XUE Bo-yu  ZHOU Ming  
Institution:YE Fang,XUE Bo-yu,ZHOU Ming,et al.Institute of Acute and Obstinate Disease,Chinese Medicine,The first Clinical College,Nanjing University of TCM
Abstract:Objective: To estimate Ziqi Ruangan tablet's influence on TGF-β1 and TIMP-1 expressed in the rat model for hepatic fibrosis with damp heat and toxic syndrome. Methods: Rats, fed with CCl4, high fat and alcohol, were divided into four groups, normal group and model group, Ziqi Ruangan tablet group and colchieine one. Investigate rats' signs changes and detect the levels of HA, LN, PⅢP, TGF-β1, TIMP-1 after 4 weeks and 8 weeks, respectively. Results: The levels of HA, LN, PIIIP, TGF-β1, TIMP-1 were varied in different degree, and become devastated even more with the disease progressed. Rats in groups of Ziqi Ruangan tablet and colchieine were in better condition, especially in group of Ziqi Ruangan tablet (P 〈 0.05 or P 〈 0. 01 ) . Conclusion: The mechinism of Ziqi Ruangan tablet's effect on the hepatic fibrosis lies in prohibiting fibrosis hyperplasia, restricting expressing of TGF-β1 and TIMP-1.
Keywords:hepatic fibrosis  model  Ziqi Ruangan tablet/pharmaeudynamies  TGF-β1  TIMP-1
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号